Publication | Closed Access

Probabilistic cost-effectiveness analysis of the long-term effect of universal hepatitis B vaccination: An experience from Taiwan with high hepatitis B virus infection and Hepatitis B e Antigen positive prevalence

VaccinationLong-term EffectInfectious Disease PreventionHealth EconomicsViral HepatitisHepatitis BHepatitisVaccine EfficacyCost EffectivenessPublic HealthEconomic EvaluationMedicineEpidemiologyProbabilistic Cost-effectiveness Analysis